Skip to content

Therapeutic effect and mechanism of phlegm-resolving therapy on coronary atherosclerosis in Lingnan area

Therapeutic effect and mechanism of phlegm-resolving therapy on coronary atherosclerosis in Lingnan area

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020501
Enrollment
Unknown
Registered
2019-01-03
Start date
2015-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Group 1:Shenzhu Guanxin Recipe Granules
Group 2:placebo

Sponsors

Guangdong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. In patients with coronary atherosclerotic heart disease diagnosed by clinical and examination, coronary CT showed 50-70% coronary atherosclerotic stenosis. The nature of the plaque belongs to soft plaque or mixed plaque, but without PCI or bypass surgery, TCM syndrome differentiation belongs to phlegm-stasis syndrome, a total of 60 cases; 2. Aged 18 to 70 years old; 3. Long-term life in Lingnan area. (Residence > 3 years, annual > 9 months); 4. Informed consent of this study and signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors; 2. Pregnant and lactating women, and those allergic to traditional Chinese medicine; 3. Complicated with severe infections, severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, and psychiatric patients; 4. Those with congenital metabolic abnormalities or immune diseases; 5. Those who take other medicines or take medicines in combination with other chronic diseases; 6. Poor compliance is expected and regular visits cannot be made; 7. Participating in other clinical trials in the last three months; 8. Researchers believe that there are other situations that are not suitable for the experiment.

Design outcomes

Primary

MeasureTime frame
coronary CT image;blood lipids;

Contacts

Public ContactDanping Xu

Guangdong Hospital of Traditional Chinese Medicine

xudanping@hotmail.com+86 13826406099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026